Literature DB >> 12227456

Intestinal function in glycogen storage disease type I.

G Visser1, J P Rake, F T M Kokke, P G J Nikkels, P J J Sauer, G P A Smit.   

Abstract

Glycogen storage disease type I (GSD I) (McKusick 232200) is caused by inherited defects of the glucose-6-phosphatase complex. Patients with GSD Ia as well as patients with GSD lb may suffer from intermittent diarrhoea, which seems to worsen with age. The cause of this diarrhoea is unknown. This study describes the results of investigations of intestinal functions and morphology in patients with GSD Ia and GSD lb, which were performed to detect a common cause for chronic diarrhoea in GSD I. The following were investigated: faecal fat excretion, faecal alpha1-antitrypsin and faecal chymotrypsin, expiratory H2 concentrations, persorption of cornstarch in urine and colonic biopsies. With the investigations presented in this study, no common cause for diarrhoea in GSD I was found. In GSD lb loss of mucosal barrier function due to inflammation, documented by increased faecal alpha1-antitrypsin excretion (3.5-9.6 mg/g dry faeces) and inflammation in the colonic biopsies, seems to be the main cause. The inflammation is most likely related to disturbed neutrophil function, which is often found in GSD lb. Whether another cause is involved in GSD Ia and in GSD Ib, related to the disturbed function of glucose-6-phosphatase in the enterocyte, remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227456     DOI: 10.1023/a:1016572706488

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.

Authors:  G Visser; J P Rake; J Fernandes; P Labrune; J V Leonard; S Moses; K Ullrich; G P Smit
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors.

Authors:  T F Roe; T D Coates; D W Thomas; J H Miller; V Gilsanz
Journal:  N Engl J Med       Date:  1992-06-18       Impact factor: 91.245

3.  STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.

Authors:  J B FIELD; S EPSTEIN; T EGAN
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

4.  Odd forms of inflammatory bowel disease: what can they tell us?

Authors:  F Shanahan; C N Bernstein
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

5.  Systemic amyloidosis complicating inflammatory bowel disease.

Authors:  S Meyers
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

6.  Oral cornstarch therapy: is persorption harmless?

Authors:  R Gitzelmann; M A Spycher
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

7.  Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.

Authors:  H Schroten; J Roesler; T Breidenbach; U Wendel; J Elsner; S Schweitzer; C Zeidler; S Burdach; M L Lohmann-Matthes; V Wahn
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

8.  Transmembrane topology of glucose-6-phosphatase.

Authors:  C J Pan; K J Lei; B Annabi; W Hemrika; J Y Chou
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

9.  Disordered intestinal function in glycogen storage disease.

Authors:  P J Milla; D A Atherton; J V Leonard; O H Wolff; B D Lake
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

Review 10.  Glycogen storage disease in adults.

Authors:  G M Talente; R A Coleman; C Alter; L Baker; B I Brown; R A Cannon; Y T Chen; J F Crigler; P Ferreira; J C Haworth; G E Herman; R M Issenman; J P Keating; R Linde; T F Roe; B Senior; J I Wolfsdorf
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

View more
  10 in total

Review 1.  Dietary dilemmas in the management of glycogen storage disease type I.

Authors:  Kaustuv Bhattacharya
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

2.  Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients.

Authors:  Gepke Visser; Wilco de Jager; Liesbeth P Verhagen; G Peter A Smit; Frits A Wijburg; Berent J Prakken; Paul J Coffer; Miranda Buitenhuis
Journal:  J Inherit Metab Dis       Date:  2011-08-24       Impact factor: 4.982

Review 3.  Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.

Authors:  Fabienne Rajas; Julie Clar; Amandine Gautier-Stein; Gilles Mithieux
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 4.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

5.  A novel starch for the treatment of glycogen storage diseases.

Authors:  K Bhattacharya; R C Orton; X Qi; H Mundy; D W Morley; M P Champion; S Eaton; R F Tester; P J Lee
Journal:  J Inherit Metab Dis       Date:  2007-05-19       Impact factor: 4.982

6.  Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.

Authors:  Elizabeth D Brooks; Dustin J Landau; Jeffrey I Everitt; Talmage T Brown; Kylie M Grady; Lauren Waskowicz; Cameron R Bass; John D'Angelo; Yohannes G Asfaw; Kyha Williams; Priya S Kishnani; Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2018-07-24       Impact factor: 4.982

7.  Generation of mice with a conditional allele for G6pc.

Authors:  Wen-Tao Peng; Chi-Jiunn Pan; Eric J Lee; Heiner Westphal; Janice Y Chou
Journal:  Genesis       Date:  2009-09       Impact factor: 2.487

Review 8.  New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation.

Authors:  Giorgos Bamias; Daniele Corridoni; Theresa T Pizarro; Fabio Cominelli
Journal:  Cytokine       Date:  2012-07-12       Impact factor: 3.861

9.  A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study.

Authors:  Kaustuv Bhattacharya; Helen Mundy; Maggie F Lilburn; Michael P Champion; David W Morley; François Maillot
Journal:  Orphanet J Rare Dis       Date:  2015-02-15       Impact factor: 4.123

10.  Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.

Authors:  J P Rake; G Visser; D Huismans; S Huitema; E van der Veer; D A Piers; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.